Stocktoria

KYNTRA BIO, INC. KYNB

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-11-14

KYNTRA BIO, INC. statistics & valuation

Market cap$29.3M
P / E0.2×
P / S4.6×
Net margin2848.6%
FCF margin-74.7%
Return on capital-50.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-31.70% -92.30% -40.60% -30.00% -107.40% -123.30% -208.70% -607.30% -160.60% 2848.60% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-27.30% -89.50% -40.70% -34.80% -108.80% -122.60% -213.90% -689.50% -507.80% -712.70% 2016201720182019202020212022202320242025
Return on equity (%)
-37.30% -22.10% -16.40% -14.40% -42.90% -126.60% 2016201720182019202020212022202320242025
Shares outstanding
63.7M 82.5M 85.4M 87.7M 91.4M 92.9M 94.2M 98.8M 4.0M 4.0M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-12.40% -13.50% -9.80% -9.00% -22.90% -37.50% -48.10% -67.10% -22.20% 153.40% 2016201720182019202020212022202320242025
Free cash flow margin (%)
3.20% -57.30% -39.50% -32.90% 44.00% -37.20% -106.40% -678.50% -466.80% -74.70% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$2.11 -$3.14 -$3.14 -$2.92 -$11.89 $45.37 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-712.7%-507.8%-689.5%-213.9%-122.6%-108.8%-34.8%-40.7%-89.5%-27.3%
Net margin2848.6%-160.6%-607.3%-208.7%-123.3%-107.4%-30.0%-40.6%-92.3%-31.7%
FCF margin-74.7%-466.8%-678.5%-106.4%-37.2%44.0%-32.9%-39.5%-57.3%3.2%
Return on assets153.4%-22.2%-67.1%-48.1%-37.5%-22.9%-9.0%-9.8%-13.5%-12.4%
Return on equity-610.7%21.1%139.2%1369.2%-126.6%-42.9%-14.4%-16.4%-22.1%-37.3%
Current ratio3.391.471.521.802.104.636.847.758.714.09

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.